Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,544 | 332 | 72.8% |
| Travel and Lodging | $2,322 | 10 | 25.8% |
| Education | $120.58 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,734 | 28 | $0 (2023) |
| Astellas Pharma US Inc | $832.23 | 38 | $0 (2024) |
| Teleflex LLC | $744.99 | 14 | $0 (2024) |
| PFIZER INC. | $473.10 | 40 | $0 (2024) |
| COLOPLAST CORP | $395.39 | 12 | $0 (2024) |
| Antares Pharma, Inc. | $355.41 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $287.71 | 21 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $240.80 | 17 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $239.86 | 10 | $0 (2024) |
| Myovant Sciences Inc. | $222.50 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $838.23 | 41 | Teleflex LLC ($160.57) |
| 2023 | $802.83 | 43 | Sumitomo Pharma America, Inc. ($108.50) |
| 2022 | $604.62 | 32 | Medtronic, Inc. ($133.67) |
| 2021 | $1,220 | 44 | Teleflex LLC ($555.82) |
| 2020 | $215.46 | 12 | Baxter Healthcare ($42.65) |
| 2019 | $619.25 | 44 | PFIZER INC. ($122.67) |
| 2018 | $3,555 | 82 | BOSTON SCIENTIFIC CORPORATION ($2,616) |
| 2017 | $1,131 | 47 | Astellas Pharma US Inc ($568.12) |
All Payment Transactions
345 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: HORMONE THERAPY | ||||||
| 11/27/2024 | COLOPLAST CORP | Coloplast TFL Drive (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Endourology | ||||||
| 11/26/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Medical Urology | ||||||
| 11/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: HORMONE THERAPY | ||||||
| 10/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/26/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $38.74 | General |
| Category: Medical Urology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $20.27 | General |
| 09/04/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: HORMONE THERAPY | ||||||
| 07/31/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/24/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Continence Care | ||||||
| 07/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/17/2024 | Teleflex LLC | SOLESTA (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 07/01/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ONCOLOGY | ||||||
| 06/05/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Prostate cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,737 | 5,443 | $2.2M | $307,609 |
| 2022 | 41 | 3,791 | 8,524 | $2.8M | $391,128 |
| 2021 | 53 | 4,218 | 7,073 | $3.6M | $463,484 |
| 2020 | 37 | 3,287 | 5,137 | $1.7M | $265,001 |
All Medicare Procedures & Services
178 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 738 | 1,313 | $932,230 | $130,110 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 289 | 373 | $186,873 | $26,180 | 14.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 195 | 202 | $146,046 | $21,029 | 14.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 215 | 294 | $112,308 | $18,714 | 16.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 56 | 68 | $91,324 | $13,944 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $80,520 | $10,768 | 13.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 20 | 273 | $31,668 | $9,388 | 29.6% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 177 | 193 | $51,917 | $7,411 | 14.3% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 22 | 22 | $46,992 | $6,704 | 14.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 46 | $45,448 | $6,421 | 14.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 218 | 266 | $34,048 | $4,871 | 14.3% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 28 | 28 | $30,324 | $4,684 | 15.4% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 20 | 63 | $14,679 | $4,334 | 29.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $26,554 | $3,580 | 13.5% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 12 | 12 | $22,836 | $3,221 | 14.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 29 | 30 | $42,270 | $3,218 | 7.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 32 | 43 | $57,749 | $2,688 | 4.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 698 | 1,145 | $18,893 | $2,509 | 13.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 31 | $15,593 | $2,381 | 15.3% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 199 | 221 | $17,238 | $2,324 | 13.5% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 20 | 63 | $7,308 | $2,166 | 29.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 19 | $13,509 | $2,050 | 15.2% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 26 | 26 | $13,962 | $1,801 | 12.9% |
| G0452 | Molecular pathology procedure; physician interpretation and report | Office | 2023 | 38 | 42 | $4,274 | $1,640 | 38.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 22 | 22 | $40,480 | $1,555 | 3.8% |
About Dr. John Chapman, MD
Dr. John Chapman, MD is a Urology healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811971377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Chapman, MD has received a total of $8,986 in payments from pharmaceutical and medical device companies, with $838.23 received in 2024. These payments were reported across 345 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,544).
As a Medicare-enrolled provider, Chapman has provided services to 15,033 Medicare beneficiaries, totaling 26,177 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 178 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Brick, NJ
- Active Since 11/30/2005
- Last Updated 08/30/2018
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1811971377
Products in Payments
- AMS (Device) $2,565
- UroLift System (Device) $584.42
- XTANDI (Drug) $560.64
- ORGOVYX (Drug) $401.98
- XYOSTED (Drug) $279.13
- Myrbetriq (Drug) $268.88
- TITAN (Device) $248.09
- PROVENGE (Drug) $239.86
- XIAFLEX (Biological) $213.98
- INTERSTIM (Device) $198.14
- Erleada (Drug) $155.45
- Androgel (Drug) $149.79
- ELIGARD (Drug) $149.07
- Xtandi (Drug) $147.58
- Natesto (Drug) $121.82
- Noctiva (Drug) $110.37
- Axonics r-SNM System (Device) $100.04
- NOCDURNA (Drug) $88.96
- ERLEADA (Drug) $87.88
- Trelstar (Drug) $80.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Brick
Dr. Mina Fam, Md, MD
Urology — Payments: $30,857
Daniel Burzon, Md, MD
Urology — Payments: $4,718
Dr. Carrie Fitzgerald, Do Mph, DO MPH
Urology — Payments: $2,939
James Rotolo, M.d, M.D
Urology — Payments: $2,860
Andrew Simon, M.d, M.D
Urology — Payments: $2,213
Gary Linn, Md, MD
Urology